Document is current

Article History

Received: 1 October 2024

Accepted: 7 December 2024

First Online: 19 December 2024

Declarations

:

: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. EMC has received honoraria for lectures from Amgen, Bristol Myers Squibb, Merck Sharp & Dohme, Novartis, Pierre Fabre, Regeneron; honoraria for a consultant or advisory role from Bristol Myers Squibb, Merck Sharp & Dohme, Novartis, Pierre Fabre, Roche, Sanofi, Regeneron; research funding from Merck Sharp & Dohme, Sanofi, Bristol Myers Squibb; has been the principal investigator in clinical trials sponsored by Amgen, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Pierre Fabre, Roche, Sanofi, Iovance, Regeneron. JC has received funding via their institution from Sanofi/Regeneron, Castle-Biosciences; honoraria for lectures from Regeneron, Almirall, Sun Pharma, Kyowa; honoraria for expert testimony from Sanofi, Regeneron, Almirall; travel support from Pfizer, Almirall, Lilly, Castle-Biosciences; honoraria for advisory board participation from Almirall, Sanofi, Regeneron, Kyowa, Roche, InflaRx; and research funding by Gerencia Regional de Salud de Castilla y León (GRS2549/A/22) and by the Instituto de Salud Carlos III (PI21/01207), co-financed by the European Union. AGC has received honoraria for scientific and commercial events from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, Sanofi Aventis; honoraria for advisory board participation from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono; and travel support from Bristol Myers Squibb, Merck Sharp & Dohme. SPS has received honoraria for a consultant or advisory role from ISDIN, La Roche–Posay, Pierre, Fabre, Sanofi, Regeneron, Sunpharma, Cantabria; research funding from ISDIN, La Roche–Posay, Pierre Fabre, Sanofi, Regeneron, Sunpharma, MSD, Castle. OSJ has received honoraria for lectures from Sunpharma, Almirall, Sanofi; and they coordinate the dermato-oncology and surgery group of the Spanish Academy of Dermatology and Venereology. ASR has received honoraria for lectures from Novartis Pharma, Pierre-Fabre, Bristol Myers Squibb, Merck Sharp & Dohme, Regeneron, Sun Pharma, Sanofi Aventis; research funding from Sanofi Aventis; honoraria for a consultant or advisory role from Novartis Pharma, Pierre-Fabre, Bristol Myers Squibb, Merck Sharp & Dohme, Regeneron, Sun Pharma, Sanofi Aventis; and travel support from Pierre Fabre, Bristol Myers Squibb, Merck Sharp & Dohme. ABJ has received honoraria for lectures from Bristol Myers Squibb, Merck Sharp & Dohme, Roche, Novartis, Pierre Fabre, Merck-Pfizer, Sanofi, Immunocore; honoraria for a consultant or advisory role from Bristol Myers Squibb, Merck Sharp & Dohme, Roche, Novartis, Pierre Fabre. Merck-Pfizer, Sanofi, Immunocore. VJ, AMLL, JOBS, AGC, PG, MTP, and AR declare no conflicts of interest.

: This study did not involve humans and did not require approval by an Ethical Committee.

: This study did not involve humans and informed consent was not necessary.